Marker Therapeutics, Inc. (MRKR)

2.19 +0.07 (+3.30%) USD  |  NASDAQ  |  Jan 21, 16:00
2.20 +0.01 (+0.46%) Pre-Market: 09:18
More

Marker Therapeutics Preferred Stock Dividend (Quarterly)

Preferred Stock Dividend (Quarterly) Chart

View Preferred Stock Dividend (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock Dividend (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock Dividend (Quarterly) Range, Past 5 Years

View Preferred Stock Dividend (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock Dividend (Quarterly) Benchmarks

View Preferred Stock Dividend (Quarterly) Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade